Ocular Therapeutix, Inc.
OCUL
$11.04
$0.282.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -265.94M | -249.67M | -216.75M | -192.71M | -193.51M |
| Total Depreciation and Amortization | 4.32M | 4.03M | 3.92M | 3.85M | 3.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 49.02M | 44.91M | 31.20M | 35.10M | 65.27M |
| Change in Net Operating Assets | 7.71M | 10.67M | 5.73M | 8.31M | -10.23M |
| Cash from Operations | -204.88M | -190.06M | -175.90M | -145.46M | -134.68M |
| Capital Expenditure | -12.01M | -9.37M | -3.47M | -2.97M | -1.29M |
| Sale of Property, Plant, and Equipment | 130.00K | 130.00K | 130.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.88M | -9.24M | -3.34M | -2.97M | -1.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 561.72M | 116.86M | 110.68M | 15.07M | 332.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 561.72M | 116.86M | 110.68M | 15.07M | 332.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 344.96M | -82.45M | -68.56M | -133.36M | 196.15M |